Investigation of Multiligamentous Knee Injury Patterns With Associated Injuries Presenting at a Level I Trauma Center

OBJECTIVES:To characterize multiligamentous knee injury patterns and describe associated morbidities. DESIGN:Retrospective. SETTING:Level I trauma center. PATIENTS:One hundred two patients (106 knees) with multiligamentous knee injuries and/or dislocations from 2000 through 2008. Subgroup of 82 knees with appropriate magnetic resonance images available assessed for ligamentous injury patterns. INTERVENTION:Data obtained from medical records for 106 knees. MAIN OUTCOME MEASUREMENTS:Presence of arterial injuries, nerve injuries, associated fracture patterns, and whole-body morbidities. RESULTS:The most common (43%) injury pattern was a combined disruption of the anterior cruciate ligament, posterior cruciate ligament, and posterolateral corner. Twenty-five percent of knees had associated ipsilateral tibial plateau fractures, and 19% had associated ipsilateral femoral fractures. Peroneal nerve injury occurred in 25% of knees, arterial injury in 21%, and compartment syndrome in 16%. An intra-abdominal injury was present in 13% of patients, a severe closed head injury in 10%, and a symptomatic pulmonary embolism in 5%. CONCLUSIONS:Nearly half the multiligamentous knee injuries involved the anterior cruciate ligament, posterior cruciate ligament, and posterolateral corner; one-fourth had associated ipsilateral tibial plateau fractures. The incidence of peroneal nerve injury (25%) was higher than previously reported (20%), whereas the incidence of arterial injury (21%) was comparable to previous reports (19%). Posterolateral corner injuries were more prevalent than previously reported and were highly associated with peroneal nerve injury. We found a substantial incidence of associated morbidities of the whole body. Multiligamentous knee injuries are a marker of concomitant trauma and should be closely evaluated at presentation and during the hospital course to allow for early intervention for life- or limb-threatening comorbidities. LEVEL OF EVIDENCE:Prognostic level IV. See Instructions for Authors for a complete description of levels of evidence.